Federal Register #DEA-1758

DEA Notice: Import Registration for Hydromorphone and Morphine (Analytical Use)

This opportunity concerns Galephar Pharmaceutical Research Inc.'s application to import controlled substances for analytical purposes, as overseen by the Drug Enforcement Administration (DEA). - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEMs and Vendors: - Galephar Pharmaceutical Research Inc. (applicant) - Products Requested: - Hydromorphone (drug code 9150) - Schedule II controlled substance - Quantity not specified - For analytical purposes only - Morphine (drug code 9300) - Schedule II controlled substance - Quantity not specified - For analytical purposes only - Unique Requirements: - Importation is strictly for analytical purposes; no commercial sale or finished dosage forms permitted - Registration approval contingent on compliance with legal requirements - DEA is soliciting comments, objections, and hearing requests from registered bulk manufacturers and applicants - No other OEMs or vendors are mentioned in the notice - The DEA is the sole government buyer involved

Description

Galephar Pharmaceutical Research Inc. has applied to be registered as an importer of basic classes of controlled substances, specifically Hydromorphone and Morphine, both Schedule II drugs. The company plans to import these substances for analytical purposes only, with no other activities authorized under this registration. Approval of permit applications will be contingent on the registrant's business activity being consistent with legal requirements, and authorization does not extend to the import of finished dosage forms for commercial sale. Comments, objections, and hearing requests regarding this application are due by September 24, 2026.

View original listing